Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
anal cancer
Aug 9, 2024, 02:02 |
Insight
ASCO24 Abstracts Not To Miss by Earle Burgess
Earle Burgess, Genitourinary Medical Oncologist at Atrium Health, Levine Cancer Institute, recently shared posts on…
Aug 8, 2024, 20:04 |
Insight
Yakup Ergün: Is completion axillary lymph node dissection necessary for adjuvant CDK4/6 inhibitors?
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: “SENOMAC post-hoc analysis: Is…
Aug 8, 2024, 15:02 |
Insight
Myeloma Paper of the Day, August 8th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Single center study confirms achieving…
Aug 7, 2024, 16:50 |
Blog
The recipients of the 2024 ESMO Society Awards
The 2024 ESMO Society Awards have been announced on 6th August by ESMO. ESMO recently…
Aug 7, 2024, 16:37 |
Blog
2024 ASCO Breakthrough Featured Voices
The ASCO Breakthrough conference, hosted by the American Society of Clinical Oncology (ASCO), is a…
Aug 7, 2024, 12:11 |
Insight
Delineating the Role of Mitochondrial Dysregulation in Richter’s Transformation
Chronic lymphocytic leukemia (CLL) is a mature B cell disease identified by the aberrant expression…
Aug 7, 2024, 11:11 |
Drugs
Earle Burgess: Important information for those who use enfortumab vedotin in practice
Earle Burgess, Genitourinary Medical Oncologist at Atrium Health Levine Cancer, shared on LinkedIn: "Key question…
Aug 7, 2024, 10:08 |
Blog
QUANTRO Therapeutics secures Austrian research grant to accelerate development of their platform
QUANTRO Therapeutics, a pioneer in the discovery of first-in-class transcription factor targeting cancer treatments, announced…
Aug 7, 2024, 01:22 |
Insight
8 years of follow-up in the CheckMate 214 trial
Yüksel Ürün shared a paper by Nizar M. Tannir et al. on X: "Nivolumab +…
Aug 6, 2024, 11:47 |
Drugs
FDA Grants Accelerated Approval to Afamitresgene Autoleucel (TECELRA) for Treating Advanced Synovial Sarcoma
On August 2, 2024, the FDA made history by granting accelerated approval to afamitresgene autoleucel…
47
48
49
50
51
All:
924
Posts:
481 - 490
Matti Aapro is running for the UICC Board of Directors
CityU-AFCR Symposium on Precision Medicine and Digital Medicine
New management team at St. Anna Children's Hospital
Key Inspirational Moments with WHO Director at the Olympic Games
Remembering Susan Wojcicki, Honoring a Legacy of Leadership and Technological Innovation
Facebook
RSS Feed
Twitter
Linkedin
Youtube